MIAMI–(BUSINESS WIRE)–OpenEvidence, the most widely-used AI platform by doctors in America, announced today that it closed a Series D round of funding, valuing the company at $12 billion. This makes OpenEvidence the most valuable Healthcare AI…
OpenEvidence also announces the wide release of OpenEvidence DeepConsult™—the first AI agent purpose-built for physicians CAMBRIDGE, Mass., July 15, 2025 /PRNewswire/ — OpenEvidence, the most widely used medical search and AI application among verified U.S. clinicians, today announced…
CAMBRIDGE, Mass., Feb. 19, 2025 /PRNewswire/ — OpenEvidence, the fastest-growing platform for doctors in history, has closed a Series A with Sequoia Capital at a $1 billion valuation. This milestone marks OpenEvidence’s first institutional investment and brings the company’s…